CD274 and neoplasm: He et al. used nanoscale coordination polymer core–shell nanoparticles containing oxaliplatin in the core part and PS pyrophospholipid conjugates (pyrolipid) in the shell part to provide combined anti-PD-L1 therapy (NCP-pyrolipid) of treated tumor cells and showed tumor cell exposure to CRT, anticancer immunity, increased tumor cell apoptosis, and an aspirin effect [9,115].